BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Hoosier Cancer Research Network
University of California, Irvine
Verastem, Inc.
Neonc Technologies, Inc.
Pfizer
Revolution Medicines, Inc.
NRG Oncology
Eli Lilly and Company
Shanghai Zhongshan Hospital
AHS Cancer Control Alberta
Shanghai Zhongshan Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Massachusetts General Hospital
M.D. Anderson Cancer Center
Maastricht University Medical Center
Eli Lilly and Company
GERCOR - Multidisciplinary Oncology Cooperative Group
AstraZeneca
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Children's Medical Center
Shanghai Zhongshan Hospital
Taiho Pharmaceutical Co., Ltd.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Sichuan University
Centre Hospitalier Universitaire de Besancon
Ruijin Hospital
Shanghai Chest Hospital
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Fudan University